1. Home
  2. CLDI vs VRME Comparison

CLDI vs VRME Comparison

Compare CLDI & VRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

HOLD

Current Price

$1.31

Market Cap

9.9M

Sector

Health Care

ML Signal

HOLD

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$0.67

Market Cap

10.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDI
VRME
Founded
2014
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.9M
10.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CLDI
VRME
Price
$1.31
$0.67
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$1.50
AVG Volume (30 Days)
75.1K
448.7K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$21,669,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$16.72
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$0.55
52 Week High
$21.24
$5.00

Technical Indicators

Market Signals
Indicator
CLDI
VRME
Relative Strength Index (RSI) 38.64 41.79
Support Level $1.41 $0.63
Resistance Level $1.52 $0.72
Average True Range (ATR) 0.09 0.07
MACD -0.02 0.00
Stochastic Oscillator 13.33 11.21

Price Performance

Historical Comparison
CLDI
VRME

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

Share on Social Networks: